American DiabetesAssociation (2004). Consensus development conference on antipsychotic drugs and obesity. Diabetes Care
Bland, R, Parker, J, Orn, H (1978). Prognosis in schizophrenia: prognostic predictors and outcome. Archives of General Psychiatry
Bleuler, M (1978). The Schizophrenic Disorders: Long-Term Patient and Family Studies. Yale University Press: New Haven.
Bola, J, Mosher, L (2002). At issue: predicting drug-free treatment response in acute psychosis from the Soteria project. Schizophrenia Bulletin
Bonner-Jackson, A, Harrow, M, Rosen, C (2010). Neurocognition in schizophrenia: a 20-year multi-follow-up of the course of processing speed and stored knowledge. Comprehensive Psychiatry
Bosveld-van Haandel, L, Slooff, C, van den Bosch, R (2001). Reasoning about the optimal duration of prophylactic antipsychotic medication in schizophrenia: evidence and arguments. Acta Psychiatrica Scandinavica
Buchanan, R, Kreyenbuhl, J, Kelly, D, Noel, J, Boggs, D, Fischer, B, Himelhoch, S, Fang, B, Peterson, E, Aquino, P, Keller, W (2010). The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophrenia Bulletin
Burdick, K, Harrow, M, Goldberg, J (2006). Neurocognition as a stable endophenotype in bipolar disorder and schizophrenia. Journal of Nervous and Mental Disease
Carone, J, Harrow, M, Westermeyer, J (1991). Posthospital course and outcome in schizophrenia. Archives of General Psychiatry
Carpenter, Jr. WT, Appelbaum, PS, Levine, RJ (2003). The Declaration of Helsinki and clinical trials: a focus on placebo-controlled trials in schizophrenia. American Journal of Psychiatry
Chouinard, G, Jones, BD (1980). Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics. American Journal of Psychiatry
Cohen, P, Cohen, J (1984). The clinician's illusions. Archives of General Psychiatry
Cornblatt, BA, Carrión, RE, Addington, J, Seidman, L, Walker, EF, Cannon, TD, Cadenhead, KS, McGlashan, TH, Perkins, DO, Tsuang, MT (2011). Risk factors for psychosis: impaired social and role functioning. Schizophrenia Bulletin. Published online: 10 November 2011. doi:10.1093/schbul/sbr136.
Dibben, C, Rice, C, Laws, K, McKenna, P (2009). Is executive impairment associated with schizophrenic syndromes? A meta-analysis. Psychological Medicine
Endicott, J, Spitzer, R (1978). A diagnostic interview. Archives of General Psychiatry
Fenton, W, McGlashan, T (1987). Sustained remission in drug-free schizophrenic patients. American Journal of Psychiatry
Gilbert, PL, Harris, MJ, McAdams, LA, Jeste, DV (1995). Neuroleptic withdrawal in schizophrenic patients: a review of the literature. Archives of General Psychiatry
Goldberg, J, Harrow, M (eds) (1999). Bipolar Disorders: Clinical Course and Outcome. American Psychiatric Press: Washington, DC.
Gorham, D (1956). A proverbs test for clinical and experimental use. Psychological Reports
Gottesman, I, Shields, J (1982). Schizophrenia: The Epigenetic Puzzle. Cambridge University Press: New York.
Grinker, R, Harrow, M (eds) (1987). Clinical Research in Schizophrenia: A Multidimensional Approach. Charles C. Thomas: Springfield, IL.
Gur, RE, Calkins, ME, Gur, RC, Horan, WP, Nuechterlein, KH, Seidman, LJ, Stone, WS (2007). The Consortium on the Genetics of Schizophrenia: neurocognitive endophenotypes. Schizophrenia Bulletin
Harding, C, Brooks, G, Ashikiga, T, Strauss, J, Breier, A (1987). The Vermont longitudinal study of persons with severe mental illness: II. Long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia. American Journal of Psychiatry
Harrison, G, Hopper, K, Craig, T, Laska, E, Siegel, C, Wanderling, J, Dube, K, Ganev, K, Giel, R, an der Heiden, W, Holmberg, SK, Janca, A, Lee, PW, Leon, CA, Malhotra, S, Marsella, AJ, Nakane, Y, Sartorius, N, Shen, Y, Skoda, C, Thara, R, Tsirkin, SJ, Varma, VK, Walsh, D, Wiersma, D (2001). Recovery from psychotic illness: a 15- and 25-year international follow-up study. British Journal of Psychiatry
Harrow, M, Goldberg, J, Grossman, L, Meltzer, H (1990). Outcome in manic disorders: a naturalistic follow-up study. Archives of General Psychiatry
Harrow, M, Grossman, L, Herbener, E, Davis, E (2000). Ten-year outcome: patients with schizoaffective disorders, schizophrenia, affective disorders, and mood-incongruent psychotic symptoms. British Journal of Psychiatry
Harrow, M, Grossman, L, Jobe, T, Herbener, E (2005). Do patients with schizophrenia ever show periods of recovery? A 15-year multi-follow-up study. Schizophrenia Bulletin
Harrow, M, Hansford, B, Astrachan-Fletcher, E (2009). Locus of control: relation to schizophrenia, to recovery, and to depression and psychosis – a 15-year longitudinal study. Psychiatry Research
Harrow, M, Jobe, T (2007). Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications: a 15-year multi-follow-up study. Journal of Nervous and Mental Disease
Harrow, M, Jobe, T (2010). How frequent is chronic multiyear delusional activity and recovery in schizophrenia: a 20-year multi-follow-up. Schizophrenia Bulletin
Harrow, M, Jobe, T, Astrachan-Fletcher, E (2008). Prognosis of persecutory delusions in schizophrenia: a 20-year longitudinal study. In
Persecutory Delusions: Assessment, Theory and Treatment
(ed. Freeman, D., Garety, P. and Bentall, R.), pp. 73–90. Oxford University Press: Oxford.
Ho, BC, Andreasen, NC, Ziebell, S, Pierson, R, Magnotta, V (2011). Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Archives of General Psychiatry
Jobe, T, Harrow, M (2005). Long-term outcome of patients with schizophrenia: a review. Canadian Journal of Psychiatry
Jobe, T, Harrow, M (2010). Schizophrenia course, long-term outcome, recovery, and prognosis. Current Directions in Psychological Science
Jones, P, Murray, R, Rodgers, B, Marmot, M (1994). Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet
Katz, M, Lyerly, S (1963). Methods for measuring adjustment and social behavior in the community: I. Rationale, description, discriminative, validity and scale development. Psychological Reports
Kendler, K, Neale, M (2010). Endophenotype: a conceptual analysis. Molecular Psychiatry
Kreyenbuhl, J, Buchanan, R, Dickerson, F, Dixon, L (2010). The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2009. Schizophrenia Bulletin
Lehtinen, V, Aaltonen, J, Koffert, T, Räkköläinen, V, Syvälahti, E (2000). Two-year outcome in first-episode psychosis treated according to an integrated model. Is immediate neuroleptisation always needed?
Levenstein, D, Klein, D, Pollack, M (1966). Follow-up study of formerly hospitalized voluntary psychiatric patients: the first two years. American Journal of Psychiatry
Lieberman, J, Stroup, S, McEvoy, J, Swartz, M, Rosenheck, R, Perkins, D, Keefe, R, Davis, S, Davis, C, Lebowitz, B, Severe, J, Hsiao, J (2005). Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine
Marengo, J, Harrow, M, Rogers, C (1980). A Manual for Scoring Abstract and Concrete Responses to the Proverbs Test. ASIS/NAPS No. 03646. Microfiche Publications: New York.
Menezes, N, Arenovich, T, Zipursky, R (2006). A systematic review of longitudinal outcome studies of first-episode psychosis. Psychological Medicine
Moncrieff, J (2009). A critique of the dopamine hypothesis of schizophrenia and psychosis. Harvard Review of Psychiatry
Moncrieff, J, Leo, J (2010). A systematic review of the effects of antipsychotic drugs on brain volume. Psychological Medicine
Owens, DC, Johnstone, EC, Miller, P, Macmillan, JF, Crow, TJ (2010). Duration of untreated illness and outcome in schizophrenia: test of predictions in relation to relapse risk. British Journal of Psychiatry
President's New Freedom Commission on Health (2003). Achieving the Promise: Transforming Mental Health Care in America. University of Michigan Library: Ann Arbor, MI.
Reed, R, Harrow, M, Herbener, E, Martin, E (2002). Executive function in schizophrenia: is it linked to psychosis and poor life functioning?
Journal of Nervous and Mental Disease
Remington, G, Kapur, S (2010). Antipsychotic dosing: how much but also how often?
Samaha, AN, Seeman, P, Stewart, J, Rajabi, H, Kapur, S (2007). ‘Breakthrough’ dopamine supersensitivity during ongoing antipsychotic treatment leads to treatment failure over time. Journal of Neuroscience
Stephens, J, Pascal, R, McHugh, P (1997). Long-term follow-up of patients hospitalized for schizophrenia, 1913 to 1940. Journal of Nervous and Mental Disorders
Strauss, J, Carpenter, W (1972). The prediction of outcome in schizophrenia: I. Characteristics of outcome. Archives of General Psychiatry
Tandon, R, Belmaker, R, Gattaz, WF (2008). World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia. Schizophrenia Research
Vaillant, G (1978). A 10-year follow-up of remitting schizophrenics. Schizophrenia Bulletin
Ventura, J, Subotnik, KL, Guzik, LH, Hellemann, GS, Gitlin, MJ, Wood, RC, Nuechterlein, KH (2011). Remission and recovery during the first outpatient year of the early course of schizophrenia. Schizophrenia Research
Webber, MA, Marder, SR (2008). Better pharmacotherapy for schizophrenia: what does the future hold?
Current Psychiatry Reports
Wechsler, D (1955). Weschler Adult Intelligence Scale Manual. Psychological Corporation: New York.
White, C, Stirling, J, Hopkins, R, Morris, J, Montague, L, Tantam, D, Lewis, S (2009). Predictors of 10-year outcome of first-episode psychosis. Psychological Medicine
Zigler, E, Glick, M (2001). The developmental approach to adult psychopathology. Clinical Psychologist
Zigler, E, Levine, J (1983). Hallucinations vs. delusions: a developmental approach. Journal of Nervous and Mental Disease